In 2021, funding for health technology companies went on a tear and by July, a rush of mega-deals over $100 million had pushed the total investment to a record-breaking level. The headline from Rock Health’s mid-year funding report said it all: “Another blockbuster year…in six months.”
Things have changed, but investors cautioned that it’s not as bad as it looks.
A new Rock Health report covering the first half of the year confirms the slowdown that many had braced for: Digital health companies have raised $10.3 billion so far in 2022, compared to $15 billion in the first six months last year. The investment firm and consultancy predicts companies will raise roughly $21 billion by year-end, compared to $29 billion for all of 2021.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect